About the forum
The purpose of RDAF is to serve as a platform to exchange ideas and define actions to raise awareness of rare diseases and to improve access to treatment and patient care in Switzerland.
RDAF brings together experts from various stakeholders in the field of rare diseases.
News - 24 September 2018
Value assessment for orphan drugs in Switzerland and the EU
31 October 2018, Basel
News - 23 July 2018
New member joined the RDAF in July 2018
In July 2018, Roche joined the Rare Disease Action Forum (RDAF), which now hosts a total of 16 members. With its increased membership, the RDAF reinforces its contribution towards the development of sustainable solutions to improve the situation of patients with rare diseases in Switzerland.